Caplin Point Lab

71
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE475E01026
  • NSEID: CAPLIPOINT
  • BSEID: 524742
INR
2,754.75
-38.25 (-1.37%)
BSENSE

Sep 11, 03:30 PM

BSE+NSE Vol: 1.1 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,187.00
1,937.00
1,694.00
1,466.00
1,269.00
1,061.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,187.00
1,937.00
1,694.00
1,466.00
1,269.00
1,061.00
Expenditure (Ex Depriciation)
Stock Adjustments
-63.00
38.00
-42.00
-46.00
-31.00
82.00
Raw Materials Consumed
929.00
732.00
766.00
710.00
589.00
389.00
Power & Fuel Cost
37.00
37.00
33.00
25.00
21.00
16.00
Employee Cost
199.00
184.00
143.00
136.00
115.00
102.00
Operating Expenses
52.00
43.00
44.00
27.00
22.00
16.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
53.00
55.00
24.00
18.00
27.00
18.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
42.00
38.00
22.00
28.00
22.00
16.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,426.00
1,290.00
1,142.00
1,025.00
874.00
732.00
Operating Profit (PBDIT) excl Other Income
760.00
646.00
551.00
441.00
394.00
328.00
Other Income
115.00
96.00
66.00
55.00
38.00
23.00
Operating Profit (PBDIT)
876.00
743.00
618.00
497.00
433.00
352.00
Interest
0.00
0.00
0.00
0.00
0.00
1.00
Profit before Depriciation and Tax
875.00
742.00
617.00
496.00
432.00
350.00
Depreciation
72.00
65.00
53.00
44.00
46.00
36.00
Profit Before Taxation & Exceptional Items
802.00
676.00
564.00
451.00
385.00
313.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
802.00
676.00
564.00
451.00
385.00
313.00
Provision for Tax
153.00
135.00
103.00
74.00
77.00
62.00
Profit After Tax
649.00
541.00
461.00
376.00
308.00
251.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
2,368.00
1,962.00
1,539.00
1,191.00
914.00
675.00
Profit Available for appropriations
3,010.00
2,499.00
1,996.00
1,567.00
1,214.00
917.00
Appropriations
3,010.00
2,499.00
1,996.00
1,567.00
1,214.00
917.00
Equity Dividend (%)
400.00%
300.00%
250.00%
225.00%
200.00%
150.00%
Earnings Per Share
84.36
70.57
60.19
49.62
39.61
32.03
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 12.89% vs 14.37% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 17.61% vs 17.32% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 42.62% vs -21.79% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 20.07% vs 17.34% in Mar 2025

Compare Profit and Loss Results of Caplin Point Lab
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,187.00
5,365.00
-3,178.00
-59.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,187.00
5,365.00
-3,178.00
-59.24%
Expenditure (Ex Depriciation)
Stock Adjustments
-63.00
-224.00
161.00
71.88%
Raw Materials Consumed
929.00
2,099.00
-1,170.00
-55.74%
Power & Fuel Cost
37.00
128.00
-91.00
-71.09%
Employee Cost
199.00
888.00
-689.00
-77.59%
Operating Expenses
52.00
308.00
-256.00
-83.12%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
53.00
333.00
-280.00
-84.08%
Cost of Software developments
0.00
12.00
-12.00
-100.00%
Miscellaneous Expenses
42.00
59.00
-17.00
-28.81%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,426.00
4,180.00
-2,754.00
-65.89%
Operating Profit (PBDIT) excl Other Income
760.00
1,185.00
-425.00
-35.86%
Other Income
115.00
20.00
95.00
475.00%
Operating Profit (PBDIT)
876.00
1,205.00
-329.00
-27.30%
Interest
0.00
114.00
-114.00
-100.00%
Profit before Depriciation and Tax
875.00
1,091.00
-216.00
-19.80%
Depreciation
72.00
296.00
-224.00
-75.68%
Profit Before Taxation & Exceptional Items
802.00
794.00
8.00
1.01%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
802.00
784.00
18.00
2.30%
Provision for Tax
153.00
189.00
-36.00
-19.05%
Profit After Tax
649.00
595.00
54.00
9.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,368.00
3,059.00
-691.00
-22.59%
Profit Available for appropriations
3,010.00
3,654.00
-644.00
-17.62%
Appropriations
3,010.00
3,654.00
-644.00
-17.62%
Equity Dividend (%)
400%
175%
225.00
Earnings Per Share
84.36
24.47
59.89
244.75%
Profit And Loss - Net Sales
Net Sales 2,187.19 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.89% vs 14.37% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 760.85 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.61% vs 17.32% in Mar 2025

Profit And Loss - Interest
Interest 0.87 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 42.62% vs -21.79% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 649.69 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 20.07% vs 17.34% in Mar 2025